GlassScriptPhysician profile
Kelly L Moore
NPI 1366430241
$2,353.66
in general payments reported to CMS, 2019-2025
30 companies · $348 in 2025
The $348 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $73.75 · 2021: $58.16 · 2022: $229 · 2023: $481 · 2024: $802 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,547 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,546.85 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $342.48 | 2019-2025 | Acessa Provu System, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Coolseal Generator |
| Astellas Pharma US INC | $282.65 | 2023-2024 | Veozah, Myrbetriq |
| Saluda Medical Americas, INC. | $189.28 | 2024 | Evoke |
| Abbvie INC. | $163.24 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $137.29 | 2023-2025 | |
| Axonics, INC. | $135.56 | 2024 | Axonics, Bulkamid |
| Pfizer INC. | $133.17 | 2019-2024 | |
| Exeltis, USA INC. | $124.43 | 2019-2025 | Slynd |
| Davol INC. | $101.13 | 2024 | Arista Ah Flexitip |
| Sumitomo Pharma America, INC. | $83.03 | 2023-2025 | Myfembree |
| Coopersurgical, INC. | $77.69 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Therapeuticsmd, INC. | $77.53 | 2019-2022 | |
| Sage Therapeutics, LLC | $67.15 | 2024-2025 | Zurzuvae |
| Covidien LP | $59.43 | 2019-2020 | |
| Ethicon US, LLC | $59.43 | 2019-2024 | Stratafix |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $37.95 | 2022 | |
| Becton, Dickinson and Company | $35.64 | 2019 | |
| Genentech, INC. | $28.31 | 2023 | Avastin, Tecentriq |
| Mayne Pharma Commercial LLC | $26.09 | 2023 | |
| Si-Bone, INC. | $25.06 | 2019 | |
| Scynexis, INC. | $22.86 | 2022 | |
| Medicem INC. | $21.16 | 2023 | |
| Organon LLC | $20.15 | 2025 | Nexplanon |
| Alydia Health | $16.22 | 2021 | |
| Daiichi Sankyo INC. | $16.21 | 2019 | |
| Myovant Sciences INC. | $16.12 | 2022 | |
| Vertical Pharmaceuticals, LLC | $15.18 | 2019 | |
| Merck Sharp & Dohme LLC | $13.94 | 2022 | |
| Lupin INC. | $13.66 | 2019 | |
| Allergan, INC. | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.